927678
Pomalidomide-difluoroPEG1-C4-piperazine Hydrochloride
≥95%
同義詞:
2-(2,2-Difluoro-3-(4-(piperazin-1-yl)butoxy)propoxy)-N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)acetamide hydrochloride
登入查看組織和合約定價
全部照片(1)
About This Item
經驗公式（希爾表示法）:
C26H33F2N5O7 · xHCl
分子量：:
565.57 (free base basis)
MDL號碼:
分類程式碼代碼:
12352101
NACRES:
NA.21
推薦產品
ligand
pomalidomide
品質等級
化驗
≥95%
形狀
powder
儲存溫度
2-8°C
SMILES 字串
O=C(C(CC1)N(C2=O)C(C3=C2C=CC=C3NC(COCC(F)(F)COCCCCN4CCNCC4)=O)=O)NC1=O.Cl
InChI
1S/C26H33F2N5O7.ClH/c27-26(28,15-39-13-2-1-10-32-11-8-29-9-12-32)16-40-14-21(35)30-18-5-3-4-17-22(18)25(38)33(24(17)37)19-6-7-20(34)31-23(19)36;/h3-5,19,29H,1-2,6-16H2,(H,30,35)(H,31,34,36);1H
InChI 密鑰
VNTZNMLSYIMLPL-UHFFFAOYSA-N
應用
Protein degrader building block Pomalidomide-difluoroPEG1-C4-piperazine Hydrochloride enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. This conjugate contains a Cereblon (CRBN)-recruiting ligand, a fluorinated linker with both hydrophobic and hydrophilic moieties, and a pendant amine for reactivity with a carboxylic acid on the target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other protein degrader building blocks with a pendant amine, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition, and E3 ligase ligand.
Targeted Protein Degradation
Targeted Protein Degradation
訊號詞
Danger
危險聲明
危險分類
Repr. 1B
儲存類別代碼
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
Daniel P Bondeson et al.
Annual review of pharmacology and toxicology, 57, 107-123 (2016-10-13)
Protein homeostasis networks are highly regulated systems responsible for maintaining the health and productivity of cells. Whereas therapeutics have been developed to disrupt protein homeostasis, more recently identified techniques have been used to repurpose homeostatic networks to effect degradation of
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務